16-30 of 175
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Living RheumShared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Living RheumCan We Prevent Psoriatic Arthritis Before Diagnosis?
Laura Coates, MBChB, MRCP, PhD
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living RheumDecoding the Data: Early Biologic Use and Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Living RheumDefining the Challenge in Complex Cases of Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
Key Factors That Influence Psoriasis Diagnosis and Management
DermConsultKey Factors That Influence Psoriasis Diagnosis and Management
Christopher Bunick, MD, PhD, FAAD
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
AudioAbstractsCan FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Ryan Quigley
- advertisement
Progress and Practical Limits with AI in Psoriatic Arthritis
AudioAbstractsProgress and Practical Limits with AI in Psoriatic Arthritis
Ryan Quigley
Molecular Signals and Early Detection in Psoriatic Arthritis
Living RheumMolecular Signals and Early Detection in Psoriatic Arthritis
Navigating the Modern PsA Treatment Landscape
Living RheumNavigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living RheumRethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD
Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living RheumUnderstanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Ryan Quigley
Luigi Adamo, MD, PhD
Andrea Fava, MD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living RheumExploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
- advertisement
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living RheumCadherin-6 in Focus: Existing Antibodies, Emerging Applications
Gary S. Firestein, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsultTYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
